143 related articles for article (PubMed ID: 4040446)
1. Expression of MHC class II antigens on bile duct epithelium in experimental graft versus host disease.
Takács L; Szende B; Rot A; Diamanstein T
Clin Exp Immunol; 1985 Jun; 60(3):449-56. PubMed ID: 4040446
[TBL] [Abstract][Full Text] [Related]
2. Evidence that nonlymphoid tissue injury in acute graft-versus-host disease is limited to epithelial cells aberrantly expressing MHC antigens.
Parfrey NA; Ste-Croix H; Prud'Homme GJ
Transplantation; 1989 Oct; 48(4):655-60. PubMed ID: 2799919
[TBL] [Abstract][Full Text] [Related]
3. Expression of major histocompatibility complex class II antigens on bile duct epithelium in patients with hepatic graft-versus-host disease after bone marrow transplantation.
Miglio F; Pignatelli M; Mazzeo V; Baraldini M; Stefanini GF; Guardigli G; Bandini G; Ricci P; Tura S; Gasbarrini G
J Hepatol; 1987 Oct; 5(2):182-9. PubMed ID: 3320179
[TBL] [Abstract][Full Text] [Related]
4. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells.
Williams FH; Thiele DL
Hepatology; 1994 Apr; 19(4):980-8. PubMed ID: 8138273
[TBL] [Abstract][Full Text] [Related]
5. Early induction of MHC antigens in human liver grafts. An immunohistologic study.
Gouw AS; Huitema S; Grond J; Slooff MJ; Klompmaker IJ; Gips CH; Poppema S
Am J Pathol; 1988 Oct; 133(1):82-94. PubMed ID: 3052095
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of the induction of autoimmune disease by graft-versus-host reaction. Role of CD8+ cells in the development of hepatic and ductal lesions induced by CD4+ cells in MHC class I plus II-different host.
Suzuki K; Narita T; Yui R; Asakura H; Fujiwara M
Lab Invest; 1994 May; 70(5):609-19. PubMed ID: 8196358
[TBL] [Abstract][Full Text] [Related]
7. Histological changes of bile duct in experimental graft-versus-disease across minor histocompatibility barriers. III. Immunoelectron microscopic observations.
Nonomura A; Yoshida K; Kono N; Nakanuma Y; Ohta G
Acta Pathol Jpn; 1988 Mar; 38(3):269-80. PubMed ID: 2969170
[TBL] [Abstract][Full Text] [Related]
8. Induction of class I and class II major histocompatibility complex antigens (MHC) in rejecting human liver grafts.
Gridelli B; Colledan M; Grendele M; Rossi G; Fassati LR; Galmarini D; Lazzaro A; Malavasi F; Ippoliti G
Transplant Proc; 1989 Feb; 21(1 Pt 2):2215-6. PubMed ID: 2652715
[No Abstract] [Full Text] [Related]
9. Immortalized intrahepatic mouse biliary epithelial cells: immunologic characterization and immunogenicity.
Hreha G; Jefferson DM; Yu CH; Grubman SA; Alsabeh R; Geller SA; Vierling JM
Hepatology; 1999 Aug; 30(2):358-71. PubMed ID: 10421641
[TBL] [Abstract][Full Text] [Related]
10. An immunohistological study of human hepatic graft-versus-host disease.
Dilly SA; Sloane JP
Clin Exp Immunol; 1985 Dec; 62(3):545-53. PubMed ID: 3910317
[TBL] [Abstract][Full Text] [Related]
11. Histologic studies on the hepatic lesions induced by graft-versus-host reaction in MHC class II disparate hosts compared with primary biliary cirrhosis.
Saitoh T; Fujiwara M; Nomoto M; Kamimura T; Ishihara K; Asakura H
Am J Pathol; 1989 Aug; 135(2):301-7. PubMed ID: 2782375
[TBL] [Abstract][Full Text] [Related]
12. Acute graft-versus-host disease does not require alloantigen expression on host epithelium.
Teshima T; Ordemann R; Reddy P; Gagin S; Liu C; Cooke KR; Ferrara JL
Nat Med; 2002 Jun; 8(6):575-81. PubMed ID: 12042807
[TBL] [Abstract][Full Text] [Related]
13. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
14. Major histocompatibility complex expression in muscle of rats with graft-versus-host disease.
Ohba Y; Fujikura Y; Sawada T; Tokuda N; Morimatsu M; Fukumoto T
Histol Histopathol; 1996 Jan; 11(1):97-102. PubMed ID: 8720452
[TBL] [Abstract][Full Text] [Related]
15. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression.
Tsuneyama K; Van de Water J; Leung PS; Cha S; Nakanuma Y; Kaplan M; De Lellis R; Coppel R; Ansari A; Gershwin ME
Hepatology; 1995 Apr; 21(4):1031-7. PubMed ID: 7535733
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma gene expression during acute graft-versus-host disease: relationship to MHC induction and tissue injury.
Parfrey NA; El-Sheikh A; Monckton EA; Cockfield SM; Halloran PF; Linetsky E
J Pathol; 1999 Sep; 189(1):99-104. PubMed ID: 10451495
[TBL] [Abstract][Full Text] [Related]
17. Fas-mediated cholangiopathy in the murine model of graft versus host disease.
Ueno Y; Ishii M; Yahagi K; Mano Y; Kisara N; Nakamura N; Shimosegawa T; Toyota T; Nagata S
Hepatology; 2000 Apr; 31(4):966-74. PubMed ID: 10733554
[TBL] [Abstract][Full Text] [Related]
18. The role of TNF in hepatic histopathological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD.
El-Hayek JM; Rogers TE; Brown GR
J Leukoc Biol; 2005 Oct; 78(4):1001-7. PubMed ID: 16081594
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
Drobyski WR; Majewski D; Ozker K; Hanson G
J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR expression in bile duct damage in hepatitis C.
Danque PO; Bach N; Schaffner F; Gerber MA; Thung SN
Mod Pathol; 1993 May; 6(3):327-32. PubMed ID: 8346181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
